After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
LENZ Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of LENZ Therapeutics Inc is $934.94M. A total of 0.62 million shares were traded on the day, compared to an average of 939.09K shares.
In the most recent transaction, Olsson Shawn sold 10,000 shares of LENZ for 26.10 per share on Nov 17 ’25. After the transaction, the Chief Commercial Officer now owns 4,733 company shares. In a previous transaction on Nov 17 ’25, SHAWN OLSSON bought 40,000 shares at 25.60 per share.
Among the insiders who bought shares, MCCOLLUM JAMES W acquired of 10,500 shares on Nov 07 ’25 at a per-share price of $22.79. This resulted in the Director holding 10,500 shares of LENZ after the transaction. In another insider transaction, Chevallard Daniel R. bought 2,198 shares at $22.76 per share on Nov 07 ’25. Company shares held by the Chief Financial Officer now total 5,386.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, LENZ has a high of $50.40 and a low of $16.53.
As of this writing, LENZ has an earnings estimate of -$0.94 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.8 per share and a lower estimate of -$1.04. The company reported an EPS of -$0.46 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. LENZ’s latest balance sheet shows that the firm has $18.31M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $1.25M in liabilities at the time. Its Book Value Per Share was $6.78, while its Total Shareholder’s Equity was -$14.21M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LENZ is Buy with a score of 4.67.
